No, it’s not futuristic fiction: a contact lens with technology that imitates the effect of the human iris. Helping people with a damaged or missing iris to improve their sight and patients with chronic migraine to reduce their light sensitivity. It’s a hi-tech accomplishment that Ghent University and imec will now market: the spin-off Azalea Vision will continue developing and commercialising the contact lens.
That blinking in the morning as a reaction to the first bright light. We’re all familiar with it. That’s a sign that your irises are hard at work. They regulate the amount of light entering the eye. These adjustments are why you can see both when there’s lots of light and when night falls.
At least that’s how it’s meant to work, but for lots of unlucky people it’s not the case. An estimated 20 million people around the world suffer from an eye complaint, including a damaged or missing iris. This makes the eye much more sensitive to light, causing all kinds of consequences for their vision. They see less sharply, struggle to perceive light and, in some cases, it can even result in low vision and blindness.
But there is light at the end of the tunnel. Researchers at Ghent University and research centre imec have designed an artificial iris that imitates the human model. Picture it as an electronic contact lens that can alter the size of the pupil. Something remarkable: the lens not only regulates how much light can enter, but also the depth of field, just like a real camera.
And that’s the big difference compared to solutions already on the market. Static contact lenses with a fixed iris, artificial iris implants, or glasses with variable transparency can resolve part of the problem, but are not yet able to imitate every function of the iris. This means that the amount of light coming in is adjusted, but patients still fail to see sharply, for example.
So how does this kind of artificial iris actually work? “The lens, applied like any normal contact lens, contains LCD technology which can copy the movements of the iris with ring-shaped pixels”, explains professor Andrés Vásquez Quintero. “Movements are controlled by ultra-thin electronics, completed with a blinking detector. A photodiode, a kind of light detector, determines exactly how much light may enter.”
Not only that, the lens also consumes very limited energy, and can be charged at night on your bedside table thanks to an integrated NFC chip.
The technology driving the artificial iris is an ingenious example of microsystem technology. Integrating a range of technologies and expertise, such as flexible electronics, liquid-crystal technology, low-power chip design, photonics and hybrid integration. “With this kind of combination you could only expect an ultra compact and autonomous system, and this is certainly the case with this artificial iris”, explains business developer Frederik Leys.
Microsystem technology is big science, but also big business, and there is much demand from the commercial world to team up in the research. Ghent University is witnessing growing interest as well. Leading not only to interesting partnerships, but also to promising spin-offs within the domain.
Among them is Azalea Vision, a spin-off of imec and Ghent University. This company will continue developing the prototype of the artificial iris, allowing it to undergo clinical validation.
The ambition is to launch a contact lens on the market which offers a solution for all eye complaints causing a reduction in light sensitivity and depth of field. To fund this ambition Azalea Vision has already raised eight million euros, including almost two million euros from public funding coming from VLAIO.
Is it easier to live with HIV than with the stigma that surrounds it?
HIV, the virus that causes AIDS, surfaced in the eighties. Long gone are the times when the virus was a sure death sentence. Still, even after all these years the stubborn stigma that surrounds HIV persists. Why is that and what can be done about it?
No more painful mammograms thanks to researchers in Ghent?
Researchers around the world are looking for innovative ways to detect and treat breast cancer. So are experimental oncologist An Hendrix and medical oncologist Hannelore Denys, two top researchers from Ghent.
Can the cause of Parkinson’s be found in our intestines? “More research is required, but that costs money”
There are currently an estimated 35,000 cases of Parkinson’s in our country. This figure increases every year. In fact, it is the fastest growing neurodegenerative illness, yet we know so little about it. Professors Roosmarijn Vandenbroucke and Patrick Santens are looking to gain knowledge of the disease with their research. “But that means that particularly large sums of money are required, and these are often unavailable”, they confirm.
Imke searches for lost voices
Imke Kissel researches unilateral vocal cord paralysis and wants to develop therapies tailored to the needs of patients.